These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 28095156)

  • 1. Lung Cancer Risk Prediction Model Incorporating Lung Function: Development and Validation in the UK Biobank Prospective Cohort Study.
    Muller DC; Johansson M; Brennan P
    J Clin Oncol; 2017 Mar; 35(8):861-869. PubMed ID: 28095156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
    Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
    Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk prediction model for lung cancer incorporating metabolic markers: Development and internal validation in a Chinese population.
    Lyu Z; Li N; Chen S; Wang G; Tan F; Feng X; Li X; Wen Y; Yang Z; Wang Y; Li J; Chen H; Lin C; Ren J; Shi J; Wu S; Dai M; He J
    Cancer Med; 2020 Jun; 9(11):3983-3994. PubMed ID: 32253829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LLPi: Liverpool Lung Project Risk Prediction Model for Lung Cancer Incidence.
    Marcus MW; Chen Y; Raji OY; Duffy SW; Field JK
    Cancer Prev Res (Phila); 2015 Jun; 8(6):570-5. PubMed ID: 25873368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.
    Tammemagi CM; Pinsky PF; Caporaso NE; Kvale PA; Hocking WG; Church TR; Riley TL; Commins J; Oken MM; Berg CD; Prorok PC
    J Natl Cancer Inst; 2011 Jul; 103(13):1058-68. PubMed ID: 21606442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of impaired lung function and lung cancer prediction among never-smokers in the UK Biobank cohort.
    Warkentin MT; Lam S; Hung RJ
    EBioMedicine; 2019 Sep; 47():58-64. PubMed ID: 31495719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction of a Risk Prediction Model for Lung Cancer Based on Lifestyle Behaviors in the UK Biobank Large-Scale Population Cohort].
    Chen R; Wang J; Wang S; Tang S; Suo C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):892-898. PubMed ID: 37866943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer screening CT-based prediction of cardiovascular events.
    Mets OM; Vliegenthart R; Gondrie MJ; Viergever MA; Oudkerk M; de Koning HJ; Mali WP; Prokop M; van Klaveren RJ; van der Graaf Y; Buckens CF; Zanen P; Lammers JW; Groen HJ; Isgum I; de Jong PA
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):899-907. PubMed ID: 23769488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5 year mortality predictors in 498,103 UK Biobank participants: a prospective population-based study.
    Ganna A; Ingelsson E
    Lancet; 2015 Aug; 386(9993):533-40. PubMed ID: 26049253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study.
    Callender T; Imrie F; Cebere B; Pashayan N; Navani N; van der Schaar M; Janes SM
    PLoS Med; 2023 Oct; 20(10):e1004287. PubMed ID: 37788223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom.
    Robbins HA; Alcala K; Swerdlow AJ; Schoemaker MJ; Wareham N; Travis RC; Crosbie PAJ; Callister M; Baldwin DR; Landy R; Johansson M
    Br J Cancer; 2021 Jun; 124(12):2026-2034. PubMed ID: 33846525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of blood-based measures of liver function and urate in lung cancer risk prediction: A cohort study and health economic analysis.
    Horsfall LJ; Clarke CS; Nazareth I; Ambler G
    Cancer Epidemiol; 2023 Jun; 84():102354. PubMed ID: 36989955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probability of cancer in lung nodules using sequential volumetric screening up to 12 months: the UKLS trial.
    Marcus MW; Duffy SW; Devaraj A; Green BA; Oudkerk M; Baldwin D; Field J
    Thorax; 2019 Aug; 74(8):761-767. PubMed ID: 31028232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma.
    Jones GD; Brandt WS; Shen R; Sanchez-Vega F; Tan KS; Martin A; Zhou J; Berger M; Solit DB; Schultz N; Rizvi H; Liu Y; Adamski A; Chaft JE; Riely GJ; Rocco G; Bott MJ; Molena D; Ladanyi M; Travis WD; Rekhtman N; Park BJ; Adusumilli PS; Lyden D; Imielinski M; Mayo MW; Li BT; Jones DR
    JAMA Surg; 2021 Feb; 156(2):e205601. PubMed ID: 33355651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
    Islam SS; Schottenfeld D
    Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a risk prediction model for lung cancer: The Japan Public Health Center-based Prospective Study.
    Charvat H; Sasazuki S; Shimazu T; Budhathoki S; Inoue M; Iwasaki M; Sawada N; Yamaji T; Tsugane S;
    Cancer Sci; 2018 Mar; 109(3):854-862. PubMed ID: 29345859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Individualized Prediction Model for Long-term Lung Function Trajectory and Risk of COPD in the General Population.
    Chen W; Sin DD; FitzGerald JM; Safari A; Adibi A; Sadatsafavi M
    Chest; 2020 Mar; 157(3):547-557. PubMed ID: 31542453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in Predicting Recurrence After Resection of Node-Negative Non-Small Cell Lung Cancer.
    Thornblade LW; Mulligan MS; Odem-Davis K; Hwang B; Waworuntu RL; Wolff EM; Kessler L; Wood DE; Farjah F
    Ann Thorac Surg; 2018 Nov; 106(5):1460-1467. PubMed ID: 30031845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selecting High-Risk Individuals for Lung Cancer Screening: A Prospective Evaluation of Existing Risk Models and Eligibility Criteria in the German EPIC Cohort.
    Li K; Hüsing A; Sookthai D; Bergmann M; Boeing H; Becker N; Kaaks R
    Cancer Prev Res (Phila); 2015 Sep; 8(9):777-85. PubMed ID: 26076698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.